The price of Agilon Health Inc (NYSE:AGL) shares last traded on Wall Street rose 4.22% to $5.19.
AGL stock price is now -3.18% away from the 50-day moving average and -55.88% away from the 200-day moving average. The market capitalization of the company currently stands at $2.13B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $6, Citigroup recently initiated with Neutral rating for Agilon Health Inc (NYSE: AGL). On March 06, 2024, Barclays recently initiated its ‘Underweight’ rating on the stock quoting a target price of $5, while ‘TD Cowen’ rates the stock as ‘Market Perform’
In other news, Schwaneke Jeffrey A., Director bought 22,300 shares of the company’s stock on Nov 29 ’23. The stock was bought for $250,206 at an average price of $11.22. Upon completion of the transaction, the Director now directly owns 31,931 shares in the company, valued at $0.17 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 13 ’23, Chief Markets Officer Shaker Benjamin sold 18,750 shares of the business’s stock. A total of $337,455 was realized by selling the stock at an average price of $18.00. This leaves the insider owning 79,543 shares of the company worth $0.41 million. A total of 26.31% of the company’s stock is owned by insiders.
During the past 12 months, Agilon Health Inc has had a low of $4.41 and a high of $26.75. As of last week, the company has a debt-to-equity ratio of 0.07, a current ratio of 1.33, and a quick ratio of 1.33.
According to the Medical Care Facilities Company, earnings per share came in at -0.04, missing analysts’ expectations of -0.02 by -0.02. This compares to $0.02 EPS in the same period last year. The net profit margin was -4.54% and return on equity was -23.94% for AGL. The company reported revenue of $1.6 billion for the quarter, compared to $1.05 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 52.17 percent. For the current quarter, analysts expect AGL to generate $1.6B in revenue.
